MHC class i expression by donor hematopoietic stem cells is required to prevent NK cell attack in allogeneic, but not syngeneic recipient mice

PLoS ONE

Volumn 10, Issue 11, 2015, Pages

  Hirata, Yuichi ^a   Li, Hao Wei ^a   Takahashi, Kazuko ^a,b   Ishii, Hiroshi ^a   Sykes, Megan ^a   Fujisaki, Joji ^a  

^a Columbia University ^*  (United States)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; HLA ANTIGEN CLASS 1;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CELL CONTACT; CELL DIFFERENTIATION; CELL INTERACTION; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; GRAFT RECIPIENT; GRAFT REJECTION; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IN VIVO STUDY; MOUSE; NATURAL KILLER CELL; NONHUMAN; WILD TYPE; ADVERSE EFFECTS; ALLOTRANSPLANTATION; ANIMAL; CYTOLOGY; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENETICS; HEMATOPOIETIC STEM CELL; IMMUNOLOGY; ISOGRAFT; METABOLISM; MOLECULAR IMAGING;

ANIMALS; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION; GENE KNOCKOUT TECHNIQUES; GRAFT REJECTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS I; KILLER CELLS, NATURAL; MICE; MOLECULAR IMAGING; TRANSPLANTATION, HOMOLOGOUS; TRANSPLANTATION, ISOGENEIC;

EID: 84952700876     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0141785     Document Type: Article

References (17)

1. Bix M, Liao NS, Zijlstra M, Loring J, Jaenisch R, Raulet D (1991) Rejection of class I MHC-deficient haemopoietic cells by irradiated MHC-matched mice. Nature 349: 329-331. PMID: 1987491
2. Ohlen C, Kling G, Hoglund P, Hansson M, Scangos G, Bieberich C, et al. (1989) Prevention of allogeneic bone marrow graft rejection by H-2 transgene in donor mice. Science 246: 666-668. PMID: 2814488
3. Ohlen C, Hoglund P, Sentman CL, Carbone E, Ljunggren HG, Koller B, et al. (1995) Inhibition of natural killer cell-mediated bone marrow graft rejection by allogeneic major histocompatibility complex class I, but not class II molecules. Eur J Immunol 25: 1286-1291. PMID: 7774631
4. Fujisaki J, Wu J, Carlson AL, Silberstein L, Putheti P, Larocca R, et al. (2011) In vivo imaging of Treg cells providing immune privilege to the haematopoietic stem-cell niche. Nature 474: 216-219. doi: 10. 1038/nature10160 PMID: 21654805
5. Niederkorn JY (2006) See no evil, hear no evil, do no evil: the lessons of immune privilege. Nat Immunol 7: 354-359. PMID: 16550198
6. Niederkorn JY (2012) Ocular immune privilege and ocular melanoma: parallel universes or immunological plagiarism? Front Immunol 3: 148. doi: 10.3389/fimmu.2012.00148 PMID: 22707951
7. Li N, Wang T, Han D (2012) Structural, cellular and molecular aspects of immune privilege in the testis. Front Immunol 3: 152. doi: 10.3389/fimmu.2012.00152 PMID: 22701457
8. Huang Y, Rezzoug F, Chilton PM, Grimes HL, Cramer DE, Ildstad ST (2004) Matching at the MHC class I K locus is essential for long-term engraftment of purified hematopoietic stem cells: a role for host NK cells in regulating HSC engraftment. Blood 104: 873-880. PMID: 15054040
9. Lo Celso C, Fleming HE, Wu JW, Zhao CX, Miake-Lye S, Fujisaki J, et al. (2009) Live-animal tracking of individual haematopoietic stem/progenitor cells in their niche. Nature 457: 92-96. doi: 10.1038/ nature07434 PMID: 19052546
10. Park D, Spencer JA, Koh BI, Kobayashi T, Fujisaki J, Clemens TL, et al. (2012) Endogenous bone marrow MSCs are dynamic, fate-restricted participants in bone maintenance and regeneration. Cell Stem Cell 10: 259-272. doi: 10.1016/j.stem.2012.02.003 PMID: 22385654
11. Deguine J, Breart B, Lemaitre F, Di Santo JP, Bousso P (2010) Intravital imaging reveals distinct dynamics for natural killer and CD8(+) T cells during tumor regression. Immunity 33: 632-644. doi: 10. 1016/j.immuni.2010.09.016 PMID: 20951068
12. Lee LA, Sergio JJ, Sykes M (1996) Natural killer cells weakly resist engraftment of allogeneic, longterm, multilineage-repopulating hematopoietic stem cells. Transplantation 61: 125-132. PMID: 8560550
13. Shizuru JA, Jerabek L, Edwards CT, Weissman IL (1996) Transplantation of purified hematopoietic stem cells: requirements for overcoming the barriers of allogeneic engraftment. Biol Blood Marrow Transplant 2: 3-14. PMID: 9078349
14. Zecher D, van Rooijen N, Rothstein DM, Shlomchik WD, Lakkis FG (2009) An innate response to allogeneic nonself mediated by monocytes. J Immunol 183: 7810-7816. doi: 10.4049/jimmunol.0902194 PMID: 19923456
15. Oberbarnscheidt MH, Zeng Q, Li Q, Dai H, Williams AL, Shlomchik WD, et al. (2014) Non-self recognition by monocytes initiates allograft rejection. J Clin Invest 124: 3579-3589. doi: 10.1172/JCI74370 PMID: 24983319
16. Geldhof AB, Moser M, Lespagnard L, Thielemans K, De Baetselier P (1998) Interleukin-12-activated natural killer cells recognize B7 costimulatory molecules on tumor cells and autologous dendritic cells. Blood 91: 196-206. PMID: 9414285
17. Champsaur M, Lanier LL (2010) Effect of NKG2D ligand expression on host immune responses. Immunol Rev 235: 267-285. doi: 10.1111/j.0105-2896.2010.00893.x PMID: 20536569